Evidence map›Paper›PMID 42418530›Full record

ArticlePLoS pathogens2026

Sialic acids are a barrier to the entry of non-influenza orthomyxoviruses.

Gabriel Dupré, Jorge Moreno-García, Elias Bendl, Georg Kochs, Jérémy Dufloo, Rafael Sanjuán

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel DupréInstitute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, Paterna, València, Spain.
Jorge Moreno-GarcíaInstitute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, Paterna, València, Spain.ORCID 0009-0008-5344-3848
Elias BendlInstitute of Virology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Georg KochsInstitute of Virology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Jérémy DuflooInstitute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, Paterna, València, Spain.
Rafael SanjuánInstitute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, Paterna, València, Spain.ORCID 0000-0002-1844-545X

Funding

European Research Council Advanced GrantSpanish Ministerio de Ciencia e InnovaciónSpanish Ministerio de Ciencia, Innovación y Universidades
6 · The paper itself

Abstract

Sialic acids (SAs) are abundantly expressed on vertebrate cell surfaces and are widely recognized as key viral attachment factors, particularly for influenza viruses. However, their role remains understudied in other orthomyxoviruses, such as thogoto and quaranja viruses, which are tick-borne viruses sporadically infecting humans. Enzymatic removal of SAs increased the infectivity of Thogoto and Dhori viruses, as well as pseudotypes carrying the glycoproteins of Oz, Sinu, and Wellfleet Bay viruses. A similar effect on pseudotype infectivity was observed following the binding of specific lectins to SAs. These findings indicate that, in contrast to influenza viruses, SAs act as a barrier to the entry of these orthomyxoviruses. Experimental evolution of the Sinu and Wellfleet Bay virus glycoproteins revealed point mutations that partially overcame this barrier. Given the abundance of sialic acids in mucosal tissues, we speculate that SAs may contribute to the inability of thogoto and quaranjaviruses to transmit directly between vertebrate hosts. Our results also underscore the importance of monitoring the circulation of these viruses for potential changes in their transmission routes.

Indexed as

OrthomyxoviridaeOrthomyxoviridae InfectionsSialic AcidsVirus InternalizationAnimalsDogsHumansThogotovirusSialic Acids

Identifiers

PMID42418530
PMCPMC13367905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.